id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2006-E-0197-0001,FDA,FDA-2006-E-0197,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2006-12-15T05:00:00Z,2006,12,,,2025-12-19T00:01:54Z,,0,0,0900006480450eec
FDA-2006-E-0197-0002,FDA,FDA-2006-E-0197,Notice of Informalities from U.S. Patent and Trademark Office to Bristol-Myers Squibb Company,Other,Letter(s),2006-12-15T05:00:00Z,2006,12,,,2025-12-19T00:04:01Z,,0,0,0900006480450ef7